Asia Medical Agricultural Stock EBITDA
| AMARC Stock | 1.42 0.02 1.43% |
Asia Medical Agricultural fundamentals help investors to digest information that contributes to Asia Medical's financial success or failures. It also enables traders to predict the movement of Asia Stock. The fundamental analysis module provides a way to measure Asia Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Asia Medical stock.
Asia |
Asia Medical Agricultural Company EBITDA Analysis
Asia Medical's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Asia Medical EBITDA | 62.16 M |
Most of Asia Medical's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Asia Medical Agricultural is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
According to the company disclosure, Asia Medical Agricultural reported earnings before interest,tax, depreciation and amortization of 62.16 M. This is 93.28% lower than that of the Technology sector and 73.67% lower than that of the Scientific & Technical Instruments industry. The ebitda for all Thailand stocks is 98.41% higher than that of the company.
Asia EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Asia Medical's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Asia Medical could also be used in its relative valuation, which is a method of valuing Asia Medical by comparing valuation metrics of similar companies.Asia Medical is currently under evaluation in ebitda category among its peers.
Asia Fundamentals
| Profit Margin | 0.1 % | |||
| Operating Margin | 0.14 % | |||
| Current Valuation | 1.47 B | |||
| Shares Outstanding | 420 M | |||
| Shares Owned By Insiders | 73.64 % | |||
| Price To Book | 5.93 X | |||
| Price To Sales | 4.48 X | |||
| Revenue | 271.77 M | |||
| Gross Profit | 109.51 M | |||
| EBITDA | 62.16 M | |||
| Book Value Per Share | 0.71 X | |||
| Earnings Per Share | 0.08 X | |||
| Number Of Employees | 221 | |||
| Market Capitalization | 1.23 B | |||
| Last Dividend Paid | 0.05 |
About Asia Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Asia Medical Agricultural's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Asia Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Asia Medical Agricultural based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Asia Stock
Asia Medical financial ratios help investors to determine whether Asia Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Asia with respect to the benefits of owning Asia Medical security.